tirzepatide hims and hers Zepbound® Vial Zepbound® KwikPen® | Hims

Semaglutide is a once-weekly GLP-1 receptor agonist indicated for: Improving glycemic control in adults with Type 2 Diabetes Mellitus Chronic weight management in eligible patients, alongside a reduced-calorie diet and increased physical activity We are proud to expand our specialty injectable portfolio with a product manufactured to high-quality standards for global markets

Avoiding nearly all ultraprocessed foods, fast foods and restaurant foods Virtually all of them contain seed oils

Supports a balanced gut microbiome*

This early real-world evidence suggests tirzepatide may offer substantial benefits in people with T1D and obesity, including significant weight loss, lower insulin requirements, and modest improvements in glycaemic control, without a rise in hypoglycaemia